BenchSci

BenchSci

BenchSci

End #ReagentFail to drive #biomedicine discovery. We use #MachineLearning to create experimentspecific suggestions for #antibodies and more. Sign up free.
Type
B2b
Raised
$35M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$22,000,000
Venture capital (Series B) - 2020
Golden Venture Partners iNovia Capital Real Ventures +3
CAD $6,700,000
Venture capital (Series A) - 2019
Gradient Ventures
Team Size
1–10
Employees
Location
Headquarters
neurons.AI

BenchSci Signifies Growth of Machine Learning Product Portfolio With Appointment of Chief …

$22,000,000 Venture capital (Series B)
VentureBeat , BetaKit , FinSMEs

BenchSci raises $22 million for AI-powered drug discovery tools

CAD $6,700,000 Venture capital (Series A)
BetaKit , PE HUB

BenchSci’s total funding reaches $27 million as Gradient ups investment

BetaKit

BenchSci leads Branham Group’s list of top 25 up-and-coming Canadian companies

Funding Awards
$8,000,000 Venture capital (Series A)
BetaKit , VentureBeat

BenchSci raises $10 million Series A for antibody search engine

Science Funding Intelligent machines
FinSMEs

BenchSci Raises US$8M in Series A Funding

Funding Science
Techvibes

BenchSci Raises $10.3 Million to Analyze Antibodies with AI

Funding Science
BetaKit

BenchSci’s David Chen: Startup CTOs need to be ready for ‘unknown unknowns’

People Technology